Cargando…

Advanced therapy for hepatitis C /

Hepatologists, both researchers and front-line clinicians, now have a comprehensive guide to the treatment of patients with the HCV virus. This book focuses mainly on the efficacy and clinical use of antiviral therapies, including the use of antivirals post liver transplantation and in the presence...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: McCaughan, Geoffrey W., McHutchison, J. G., Pawlotsky, Jean-Michel
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Chichester, West Sussex : Blackwell, 2012.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn758981647
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 111028s2012 enk ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d N$T  |d UIU  |d E7B  |d YDXCP  |d EBLCP  |d MHW  |d OCLCQ  |d OCLCF  |d OCLCQ  |d CDX  |d IDEBK  |d NLGGC  |d DG1  |d OCLCQ  |d COO  |d OCLCQ  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d COCUF  |d DG1  |d CHVBK  |d OCLCO  |d MOR  |d LIP  |d OCLCO  |d PIFAG  |d ZCU  |d OCLCO  |d OCLCQ  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d U3W  |d OCLCA  |d OCLCQ  |d STF  |d WRM  |d ICG  |d VT2  |d OCLCO  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d OCLCQ  |d LEAUB  |d DKC  |d OCLCO  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCA  |d INARC  |d UKCRE  |d HS0  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 756898491  |a 768243579  |a 769262993  |a 816865412  |a 823854442  |a 823924721  |a 839374964  |a 961631610  |a 962649636  |a 965992275  |a 988429700  |a 991994413  |a 1037718646  |a 1038610819  |a 1153488985 
020 |a 9781444346312  |q (electronic bk.) 
020 |a 1444346318  |q (electronic bk.) 
020 |a 1283283239 
020 |a 9781283283236 
020 |z 9781405187459 
020 |z 140518745X 
020 |z 9781444346343 
020 |z 1444346342 
020 |z 9781444346329 
020 |z 1444346326 
020 |z 9781444346336 
020 |z 1444346334 
024 8 |a 9786613283238 
029 1 |a AU@  |b 000049641722 
029 1 |a AU@  |b 000060896519 
029 1 |a CHNEW  |b 000938406 
029 1 |a CHVBK  |b 480187134 
029 1 |a DEBBG  |b BV042796128 
029 1 |a DEBBG  |b BV043393630 
029 1 |a DEBBG  |b BV044159982 
029 1 |a DEBSZ  |b 48500786X 
029 1 |a NZ1  |b 14976057 
029 1 |a NZ1  |b 15915151 
029 1 |a AU@  |b 000069955169 
035 |a (OCoLC)758981647  |z (OCoLC)756898491  |z (OCoLC)768243579  |z (OCoLC)769262993  |z (OCoLC)816865412  |z (OCoLC)823854442  |z (OCoLC)823924721  |z (OCoLC)839374964  |z (OCoLC)961631610  |z (OCoLC)962649636  |z (OCoLC)965992275  |z (OCoLC)988429700  |z (OCoLC)991994413  |z (OCoLC)1037718646  |z (OCoLC)1038610819  |z (OCoLC)1153488985 
037 |a 328323  |b MIL 
050 4 |a RC848.H425  |b A38 2012eb 
060 4 |a WC 536 
072 7 |a MED  |x 114000  |2 bisacsh 
072 7 |a MJH  |2 bicssc 
082 0 4 |a 616.3/62306  |2 23 
049 |a UAMI 
245 0 0 |a Advanced therapy for hepatitis C /  |c edited by Geoffrey W. McCaughan, John G. McHutchison, Jean-Michel Pawlotsky. 
260 |a Chichester, West Sussex :  |b Blackwell,  |c 2012. 
300 |a 1 online resource (xi, 219 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
504 |a Includes bibliographical references and index. 
505 0 |a HCV replication / Michael R. Beard -- Hepatitis C virus genotypes / Scott A. Read and Mark W. Douglas -- Immune responses to HCV : implications for therapy / David G Bowen -- Mechanisms of action of antiviral drugs : the interferons / Edmund Tse and Michael R Beard -- Pharmacology and mechanisms of action of antibviral drugs : ribavarin analogues / Fred Poordad and Grace M. Chee -- Pharmacology and mechanisms of action of antiviral drugs : polymerase inhibitors / Lotte Coelmont [and others] -- Pharmacology and mechanisms of action of antiviral drugs : protease inhibitors / Laurent Chatel-Chaix, Martin Baril, and Daniel Lamarre -- Measuring antiviral responses / Jean-Michel Pawlotsky and Stéphane Chevaliez -- Genotype 1 : standard treatment / Rebekah G. Gross and Ira M. Jacobson -- Individually tailored treatment strategies in treatment naïve chronic hepatitis C genotype 1 patients / Johannes Wiegand and Thomas Berg -- Genotype 1 relapsers and nonresponders / Salvatore Petta and Antonio Craxì -- Standard therapy for genotype 2/3 / Kenneth Yan and Amany Zekry -- Altered dosage or durations of current antiviral therapy for HCV genotype 2 and 3 / Alessandra Mangia, Leonardo Mottola, Angelo Andriulli -- Genotype 2/3 relapse and non response / Stella Martínez, Jose Maŕia Sánchez-Tapias, and Xavier Forns -- Hepatitis C genotype 4 therapy: progress and challenges / Sanaa M. Kamal -- Antivirals in acute hepatitis C / Heiner Wedemeyer -- Antivirals in cirrhosis and portal hypertension / Diarmuid S. Manning and Nezam H. Afdhal -- Treatment of recurrent hepatitis C following liver transplantation / Ed Gane -- Antiviral treatment in chronic hepatitis C virus infection with extra hepatic manifestations / Benjamin Terrier and Patrice Cacoub -- Cytopenias : how they limit therapy and potential correction / Mitchell L. Shiffman -- The problem of insulin resistance and its effect on therapy / Venessa Pattullo and Jacob George -- HIV and hepatitis C co-infection / Gail V. Matthews and Gregory J. Dore -- HCV and racial differences / Andrew J. Muir -- HCV and the pediatric population / Kathleen B. Schwarz -- New horizons : il28; direct-acting antiviral therapy for HCV -- Alexander J. Thompson, John G. Mchutchison, Geoff W. Mccaughan. 
588 0 |a Print version record. 
520 |a Hepatologists, both researchers and front-line clinicians, now have a comprehensive guide to the treatment of patients with the HCV virus. This book focuses mainly on the efficacy and clinical use of antiviral therapies, including the use of antivirals post liver transplantation and in the presence of the HIV virus. It also explores the foundations for understanding antiviral therapies in HCV, such as the complex pharmacology and mechanisms of antiviral drugs. A 'late-breaking information' chapter contains the most recent trial results on the latest antiviral drugs. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Hepatitis C  |x Treatment. 
650 0 |a Antiviral agents. 
650 1 2 |a Hepatitis C  |x therapy 
650 2 2 |a Antiviral Agents  |x therapeutic use 
650 2 |a Antiviral Agents 
650 6 |a Hépatite C  |x Traitement. 
650 6 |a Antiviraux. 
650 7 |a MEDICAL  |x Hepatology.  |2 bisacsh 
650 7 |a Antiviral agents  |2 fast 
650 7 |a Hepatitis C  |x Treatment  |2 fast 
650 7 |a Hepatitis C.  |2 idszbz 
650 7 |a Virostatikum.  |2 idszbz 
650 7 |a Therapie.  |2 idszbz 
700 1 |a McCaughan, Geoffrey W. 
700 1 |a McHutchison, J. G. 
700 1 |a Pawlotsky, Jean-Michel. 
758 |i has work:  |a Advanced therapy for hepatitis C (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGqkmJMRdkfmB9VkqtQykC  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Advanced therapy for hepatitis C.  |d Chichester, West Sussex : Blackwell, 2012  |z 9781405187459  |w (DLC) 2011016561  |w (OCoLC)714030353 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=819327  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH21639690 
938 |a Askews and Holts Library Services  |b ASKH  |n AH21639689 
938 |a Coutts Information Services  |b COUT  |n 19349326  |c 74.99 GBP 
938 |a EBL - Ebook Library  |b EBLB  |n EBL819327 
938 |a ebrary  |b EBRY  |n ebr10501299 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 328323 
938 |a Internet Archive  |b INAR  |n advancedtherapyf0000unse 
938 |a YBP Library Services  |b YANK  |n 7191869 
938 |a YBP Library Services  |b YANK  |n 5559628 
938 |a YBP Library Services  |b YANK  |n 12674776 
994 |a 92  |b IZTAP